USANA Health Sciences (NYSE:USNA) Rating Lowered to “Hold” at Zacks Research

USANA Health Sciences (NYSE:USNA) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Wednesday,Zacks.com reports.

USNA has been the topic of several other research reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of USANA Health Sciences in a research report on Friday, March 27th. Wall Street Zen raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce”.

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $19.23 on Wednesday. The stock has a market cap of $354.91 million, a P/E ratio of 34.96, a P/E/G ratio of 0.83 and a beta of 0.71. The stock’s 50 day simple moving average is $18.69 and its 200-day simple moving average is $19.95. USANA Health Sciences has a 1-year low of $16.60 and a 1-year high of $38.32.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 17th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.19. The business had revenue of $226.20 million for the quarter, compared to analysts’ expectations of $225.96 million. USANA Health Sciences had a return on equity of 6.75% and a net margin of 1.16%. As a group, research analysts expect that USANA Health Sciences will post 1.95 EPS for the current fiscal year.

Insider Buying and Selling at USANA Health Sciences

In other news, insider Joshua Foukas sold 4,461 shares of the company’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $21.34, for a total transaction of $95,197.74. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.82% of the company’s stock.

Hedge Funds Weigh In On USANA Health Sciences

Several large investors have recently bought and sold shares of the business. Pzena Investment Management LLC increased its holdings in USANA Health Sciences by 1.2% in the third quarter. Pzena Investment Management LLC now owns 1,212,588 shares of the company’s stock valued at $33,407,000 after buying an additional 14,328 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of USANA Health Sciences by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 1,147,323 shares of the company’s stock worth $22,522,000 after buying an additional 21,793 shares during the period. Vanguard Group Inc. boosted its stake in shares of USANA Health Sciences by 5.7% during the third quarter. Vanguard Group Inc. now owns 1,069,032 shares of the company’s stock worth $29,452,000 after buying an additional 57,249 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of USANA Health Sciences by 1.9% during the third quarter. Dimensional Fund Advisors LP now owns 915,049 shares of the company’s stock worth $25,210,000 after buying an additional 17,318 shares during the period. Finally, Nantahala Capital Management LLC purchased a new position in USANA Health Sciences during the fourth quarter worth about $11,485,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.